nach oben

Erschienen in:

01.02.2010 | Review

Lupoid sclerosis

verfasst von: Briele Keiserman, Luiz Fernando Garcias da Silva, Mauro W. Keiserman, Carlos Alberto von Mühlen, Henrique Luiz Staub

Erschienen in: Rheumatology International | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Lupoid sclerosis (LS) is a controversial entity, comprising features of both systemic lupus erythematosus and multiple sclerosis. Diagnostic criteria are a matter of debate, as well as the role of antinuclear and antiphospholipid antibodies. In this review, clinical and laboratory findings of LS available on Pubmed up to date are discussed.

Feletar M, Ibanez D, Urowitz MG, Gladman DD (2003) The impact of the 1997 update of the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus: what has been changed? Arthritis Rheum 48(7):2067–2069CrossRefPubMed

Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306CrossRefPubMed

Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “MacDonald Criteria”. Ann Neurol 58:840–846CrossRefPubMed

Levine SR, Welch KM (1987) The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulant and anticardiolipin antibodies. Arch Neurol 44:876–883PubMed

Theodoridou A, Settas L (2006) Demyelination in rheumatic diseases. J Neurol Neurosurg Psychiatry 77(3):290–295PubMed

Shepherd DI, Downie AW, Best PV (1974) Systemic lupus erythematosis and multiple sclerosis. Trans Am Neurol Assoc 99:173–176PubMed

Stepien M, Cendrowski W (1974) Form of systemic lupus erythematosus (lupoid sclerosis) resembling multiple sclerosis. Neurol Neurochir Pol 8:607–609PubMed

Kaplan PE, Betts HB (1977) Lupoid sclerosis: evaluation and treatment. Arch Phys Med Rehabil 58:24–28PubMed

Ellenberg M (1978) Lupoid sclerosis. Arch Phys Med Rehabil 59:43–44PubMed

10.

Knapik-Kordecka M, Plamieniak Z (1980) Case of visceral lupus erythematosus coexisting with multiple sclerosis. Pol Tyg Lek 35(28):1075–1076PubMed

11.

Rosati G, Serra G, Trotta F, Tralli G, Artioli M (1981) Systemic lupus erythematosus and multiple sclerosis. Riv Neurobiol 27(1):158–164PubMed

12.

Hutchinson M, Bresnihan B (1983) Neurological lupus erythematosus with tonic seizures simulating multiple sclerosis. J Neurol Neurosurg Psychiatry 46(6):583–585CrossRefPubMed

13.

Hoppe B, Zajaczek-Grabowska A (1984) Diagnostic difficulties in a case of visceral lupus with disseminated neurological signs. Neurol Neurochir Pol 18:489–491PubMed

14.

Harris EN, Gharavi AE, Mackworth-Young CG, Patel BM, Derue G, Hughes GRV (1985) Lupoid sclerosis: a possible role for antiphospholipid antibodies. Ann Rheum Dis 44:281–283CrossRefPubMed

15.

Lorcerie B, Marchal G, Borsotti JP, Guard O, Giroud M, Dumas R et al (1989) Multiple sclerosis associated with biological symptoms of systemic lupus erythematosus. A case with anatomical study. Rev Med Interne 10:471–474CrossRefPubMed

16.

Moriwaka F, Tashiro K, Fukazawa T, Akino M, Yasuda I, Sagawa A, Hida K (1990) A case of systemic lupus erythematosus: its clinical and MRI resemblance to multiple sclerosis. Jpn J Psychiatry Neurol 44(3):601–605PubMed

17.

van der Kaaden AJ, Kamphuis DJ, Nossent JC, Rico RE (1993) Longstanding isolated cerebral systemic lupus erythematosus in an 8-year-old black girl. Resemblance with multiple sclerosis. Clin Neurol Neurosurg 95(3):241–244CrossRefPubMed

18.

Kinnunen E, Müllher K, Keto P, Ketonen L, Helve T, Sepponen R (1993) Cerebrospinal fluid and MRI findings in three patients with multiple sclerosis and systemic lupus erythematosus. Acta Neurol Scand 87:356–360PubMedCrossRef

19.

Dabadghao S, Aggarwal A, Misra R (1995) Lupoid sclerosis with raised anticardiolipin antibodies. J Assoc Physicians India 43:298PubMed

20.

Banerjee S, Kumar L, Singh S, Kakkar N (1997) Multiple sclerosis and systemic lupus erythematosus in a 10-year-old girl. Indian Pediatr 34(2):159–162PubMed

21.

Schantz V, Oestergaard LL, Junker P (1998) Shrinking spinal cord following transverse myelopathy in a patient with systemic lupus erythematosus and the phospholipid antibody syndrome. J Rheumatol 25(7):1425–1428PubMed

22.

Carter D, Olchovski D, Yonath H, Langevitz P, Ezra D (2006) Simultaneous deep vein thrombosis and transverse myelitis with negative sorology as a first sign of antiphospholipid syndrome: a case report and review of the literature. Clin Rheumatol 25:756–758CrossRefPubMed

23.

Lima I, Melo A, Brandi IV, Costa O, Santiago M (2007) Lupoid sclerosis: what is the role of antiphospholipid antibodies? J Clin Rheumatol 13:85–86CrossRefPubMed

24.

Kasitanon N, Louthrenoo W, Piyasirisilp S, Sukitawu W, Wichainun R (2002) Neuropsychiatric manifestations in Thai patients with systemic lupus erythematosus. Asian Pac J Allergy Immunol 20(3):179–185PubMed

25.

Kovacs B, Lafferty TL, Brent LH, DeHoratius RJ (2000) Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis 59(2):120–124CrossRefPubMed

26.

Mok CC, Lau CS, Chan EY, Wong RW (1998) Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome. J Rheumatol 25(3):467–473PubMed

27.

Inslicht DV, Stein AB, Pomerantz F, Ragnarsson KT (1998) Three women with lupus transverse myelitis: case reports and differential diagnosis. Arch Phys Med Rehabil 79(4):456–459CrossRefPubMed

28.

Zenone T, Steineur MP, Sibille M, Durieu I, Vital Durand D (2000) Myelopathy revealing lupus. Two cases and review of the literature. Rev Med Interne 21:1114–1120CrossRefPubMed

29.

D’Cruz DP, Mellor-Pita S, Joven B, Sanna G, Allanson J, Taylor J et al (2004) Transverse myelitis as the first manifestation of systemic lupus erythematosus and lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies. Rheumatology 31:280–285

30.

Téllez-Zenteno JF, Remes-Troche JM, Negrete-Pulido RO, Dávila Maldonado L (2001) Longitudinal myelitis associated with systemic lupus erythematosus: clinical features and magnetic resonance imaging of six cases. Lupus 10:851–856CrossRefPubMed

31.

Lehnhard FR, Impekoven P, Rubbert A, Burghaus L, Nevelin M, Heiss WD, Jacobs AH (2004) Recurrrent longitudinal myelitis as primary manifestation of SLE. Neurology 63(10):1976

32.

Heinlein AC, Gertner E (2007) Marked inflammation in catastrophic longitudinal myelitis associated with systemic lupus erythematosus. Lupus 16(10):823–826CrossRefPubMed

33.

Kim JH, Lee SI, Park SI, Yoo WH (2004) Recurrent transverse myelitis in primary antiphospholipid syndrome—case report and literature review. Rheumatol Int 24:244–246PubMed

34.

Takamura Y, Morimoto S, Tanooka A, Yoshikawa J (1996) Transverse myelitis in a patient with primary antiphospholipid syndrome. A case report. No To Shinkei 48:851–855PubMed

35.

Shaharao V, Bartakke S, Muranjan MN, Bavdekar MS, Bavdekar SB, Udani VP (2004) Recurrent acute transverse myelopathy: association with antiphospholipid antibody syndrome. Indian J Pediatr 71:559–561CrossRefPubMed

36.

Chapman J (2004) The interface of multiple sclerosis and antiphospholipid antibodies. Thromb Res 114:477–481CrossRefPubMed

37.

Ferreira S, D’Cruz DP, Hughes GR (2005) Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology (Oxford) 44:434–442CrossRef

38.

Suárez Alvarez L, Hughes GR, Khamashta MA (2005) Neurological manifestations of the antiphospholipid syndrome. Med Clin (Barc) 124:630–633CrossRef

39.

Ijdo JW, Conti-Kelly AM, Greco P, Abedi M, Amos Provenzale JM et al (1999) Antiphospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS? Lupus 8:109–115CrossRefPubMed

40.

Cuadrado MJ, Khamastha MA, Ballesterol A, Godfrey T, Simon MF, Hughes GR (2000) Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Medicine (Baltimore) 79:57–68CrossRef

41.

Marullo S, Clauvel JP, Intrator L, Danon F, Brouet JC, Oksenhendler E (1993) Lupoid sclerosis with antiphospholipid and antimyelin antibodies. J Rheumatol 20:747–749PubMed

42.

Inoue Y, Yoshino H (1998) Acute transverse myelitis presenting with syrinx formation associated with anti-sulfated glucuronyl lactosaminyl paragloboside antibody and anticardiolipin antibodies. No To Shinkei 50:181–185PubMed

43.

Wingerchuck DM, Hogancamp WF, O’Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology 53:1107–1114

44.

Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E et al (2004) Italian Devic’s Study Group (IDESG). Clinical characteristics, course and prognosis of relapsing Devic’s Neuromyelitis Optica. J Neurol 251:47–52CrossRefPubMed

45.

Scott TF, Kassab SL, Pittock SJ (2006) Neuromyelitis optica IgG status in acute partial transverse myelitis. Arch Neurol 63:1398–1400CrossRefPubMed

46.

Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, Vincent A, Wildemann B (2008) Vanderbilt. Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 4(4):202–214PubMed

47.

April RS, Vansonnenberg E (1976) A case of neuromyelitis optica (Devic’s syndrome) in systemic lupus erythematosus. Clinicopathologic report an review of the literature. Neurology 26:1066–1070PubMed

48.

Jacobi C, Stingele K, Kretz R, Hartmann M, Storch-Hagenlocher B, Breitbart A et al (2006) Neuromyelitis optica (Devic’s syndrome) as first manifestation of systemic lupus erythematosus. Lupus 15:107–109CrossRefPubMed

49.

Ferreira S, Marques P, Carneiro E, D’Cruz D, Gama G (2005) Devic’s syndrome in systemic lupus erythematosus and probable antiphospholipid syndrome. Rheumatology (Oxford) 44:693–695CrossRef

50.

de Seze J, Stojkovic T, Ferriby D, Gauvrit JY, Montagne C, Mounier-Vehier F et al (2002) Devic’s neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci 197:57–61CrossRefPubMed

51.

Govoni M, Padovan M, Rizzo N, Trotta F (2001) CNS involvement in primary Sjogren’s syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach. CNS Drugs 15:597–607CrossRefPubMed

52.

Mellgren SI, Göransson LG, Omdal R (2007) Primary Sjögren’s syndrome associated neuropathy. 1. Can J Neurol Sci 34(3):280–287PubMed

53.

Yamamoto T, Ito S, Hattori T (2006) Neurological picture. Acute longitudinal myelitis as the initial manifestation of Sjögren’s syndrome. J Neurol Neurosurg Psychiatry 77(6):780CrossRefPubMed

54.

Neuwelt CM, Lacks S, Kaye BR, Ellman JB, Borenstein DG (1995) Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus. Am J Med 98(1):32–41CrossRefPubMed

55.

Fukui W, Sano H, Tanabe T, Ueda T, Hirohata S, Hashiramoto A, Yamada R, Kato H, Kondo M (1998) A case of severe neuropsychiatric lupus erythematosus treated by plasmapheresis: diagnostic values of serum antiribosomal P protein antibodies and interleukin-6 in cerebrospinal fluid. Nihon Rinsho Meneki Gakkai Kaishi 21(4):172–179PubMed

56.

Taniguchi Y, Yorioka N, Okushin S, Oda H, Usui K, Yamakido M (1995) Usefulness of immunoadsorption therapy for systemic lupus erythematosus associated with transverse myelitis. A case report. Int J Artif Organs 18(12):799–801PubMed

57.

Armstrong DJ, McCarron MT, Wright GD (2006) SLE-associated transverse myelitis successfully treated with Rituximab (anti-CD20 monoclonal antibody). Rheumatol Int 26(8):771–772CrossRefPubMed

58.

Lehnhardt FG, Scheid C, Holtik U, Burghaus L, Neveling M, Impekoven P, Rüger A, Hallek M, Jacobs AH, Rubbert A (2006) Autologous blood stem cell transplantation in refractory systemic lupus erythematodes with recurrent longitudinal myelitis and cerebral infarction. Lupus 15(4):240–243CrossRefPubMed

59.

Yamawaki T, Suzuki N (1997) Can immunoadsorption plasmapheresis be used as the first choice therapy for neuroimmunological disorders? Ther Apher 1(4):348–352CrossRefPubMed

60.

Keiserman B, Garcias da Silva LF, Keiserman MW, von Mühlen CA, Staub HL (2008) Polemics on lupoid sclerosis. Rev Bras Rheumatol 48(1):62–65

Titel: Lupoid sclerosis
verfasst von: Briele Keiserman
Luiz Fernando Garcias da Silva
Mauro W. Keiserman
Carlos Alberto von Mühlen
Henrique Luiz Staub
Publikationsdatum: 01.02.2010
Verlag: Springer-Verlag
Erschienen in: Rheumatology International / Ausgabe 4/2010
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-009-1175-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Lupoid sclerosis

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2010

A rare cause of refractory ascites in a child: familial Mediterranean fever

Incomplete Kawasaki syndrome followed by systemic onset-juvenile idiopathic arthritis mimicking Kawasaki syndrome

Rheumatic manifestations of hepatitis B and C and their association with viral load and fibrosis of the liver

A case of recurrent polymyalgia rheumatica-like complications with pregnancy

Third generation anti-cyclic citrullinated peptide antibodies do not predict anti-TNF-α treatment response in rheumatoid arthritis

Gender differences in the relationship of anti-parvovirus B19 IgG with antinuclear antibody and C-reactive protein in clinical adult serum samples

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin